Join Kyia Hynes on Friday, April 26, 2026 at 10:00 PT for a webinar on Breaking the Habit: Early Discontinuation of Antibiotics in Febrile Neutropenia.
The webinar will discuss febrile neutropenia management, and review evidence supporting early discontinuation of antibiotics in patients with no identified source of infection. It will also highlight principals of antimicrobial resistance. As well as demonstrate an antimicrobial stewardship initiative that was implemented at the Arthur J.E. Child Comprehensive Cancer Centre, by applying this evidence.
Febrile neutropenia is a medical emergency that cancer patients face. However, antibiotic resistance is a global threat. Managing antibiotics for these vulnerable patients is a delicate balancing act. We want to maximize clinical benefit while minimizing unintended consequences. Historically it was thought that antibiotics should be continued until neutrophil recovery to reduce mortality. New evidence suggests otherwise.
Learning Objectives
- Define febrile neutropenia and understand empiric management.
- Understand principals of antibiotic resistance.
- Analyze evidence supporting the safety of early discontinuation of antibiotics in febrile neutropenia patients, without a source of infection.
- Apply antimicrobial stewardship initiative to febrile neutropenia patient.